BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 162963)

  • 1. A review of tumor antigens in gynecologic malignancies.
    Gall SA
    J Reprod Med; 1975 Jan; 14(1):12-6. PubMed ID: 162963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen in patients with gynecologic malignancies.
    DiSaia PJ; Haverback BJ; Dyce BJ; Morrow CP
    Am J Obstet Gynecol; 1975 Jan; 121(2):159-63. PubMed ID: 163585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated antigens in gynecologic cancer.
    DiSaia PJ
    Clin Obstet Gynecol; 1975 Dec; 18(4):87-108. PubMed ID: 765038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen in cancer of the female reproductive system: its detection in serum by a microradioimmunoassay.
    Khoo SK; Mackay EV
    Aust N Z J Obstet Gynaecol; 1973 May; 13(2):107-13. PubMed ID: 4518714
    [No Abstract]   [Full Text] [Related]  

  • 5. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
    Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
    Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphocyte function and HL-A antigen frequency in gynecologic squamous cancer. A preliminary report.
    Twomey PL; Rogentine GN; Chretien PB
    Int Surg; 1974 Sep; 59(9):468-72. PubMed ID: 4414534
    [No Abstract]   [Full Text] [Related]  

  • 8. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
    Nakajima H; Hirata T; Norisugi T; Furuno K; Ikehata N; Utsunomiya A; Kobayashi K; Negishi Y; Akiya K
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated antigen(s) from granulosa cell carcinomas of the ovary.
    Bhattacharya M; Barlow JJ; Chu TM; Piver MS
    Cancer Res; 1974 Apr; 34(4):818-22. PubMed ID: 4205513
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of T-lymphocytes in patients with a gynecologic malignancy].
    Ressel M; Köhler G
    Zentralbl Gynakol; 1984; 106(17):1192-7. PubMed ID: 6333766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
    Bhattacharya M; Barlow JJ
    Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis in malignancies of the female genital tract.
    Abulafia O; Triest WE; Sherer DM
    Gynecol Oncol; 1999 Feb; 72(2):220-31. PubMed ID: 10021305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological aspects of gynecological malignancies.
    DiSaia PJ
    J Reprod Med; 1975 Jan; 14(1):17-20. PubMed ID: 1110478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers.
    Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
    Am J Obstet Gynecol; 2000 Jul; 183(1):18-21. PubMed ID: 10920302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
    Stratton JA; Rettenmaier MA; Phillips HB; Herabutya S; DiSaia PJ
    Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on clinical significance of oncofetal antigen-1 in gynecologic tumors].
    Takahashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2613-8. PubMed ID: 6520482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.
    Ueda G; Inoue Y; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Saito J; Nishino T; Abe Y
    Int J Gynecol Pathol; 1984; 3(3):291-8. PubMed ID: 6389386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.